Clinical and Biochemical Impact of the d3 Growth Hormone Receptor Genotype in Acromegaly

Abstract

The absence of exon 3 of the GHR may be associated with a more morbid acromegalic clinical and biochemical picture and a lower chance of achieving IGF-I normalization after therapy.